Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

BACKGROUND: BAT1706 is a proposed biosimilar of bevacizumab, a vascular endothelial growth factor A (VEGF-A)-targeting biologic used to treat several different cancers, including metastatic colorectal cancer. A comprehensive physicochemical and functional similarity assessment is a key component of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Di, Deng, Chunping, Wang, Guangying, Mei, Xiong, Xie, Jianhua, Liu, Yuanmei, Liu, Yujie, Yang, Yili, Li, Shengfeng, Liu, Cuihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439073/
https://www.ncbi.nlm.nih.gov/pubmed/37479945
http://dx.doi.org/10.1007/s40268-023-00432-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439073/
https://www.ncbi.nlm.nih.gov/pubmed/37479945
http://dx.doi.org/10.1007/s40268-023-00432-8

Ejemplares similares